Citizens Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
2,659
+1,871
| +237% | +$982K | 0.02% | 300 |
|
|
2025
Q1 | $500K | Sell |
788
-465
| -37% | -$295K | 0.01% | 417 |
|
|
2024
Q4 | $893K | Sell |
1,253
-10,765
| -90% | -$7.67M | 0.02% | 313 |
|
|
2024
Q3 | $12.6M | Sell |
12,018
-112
| -0.9% | -$118K | 0.25% | 81 |
|
|
2024
Q2 | $12.7M | Buy |
12,130
+127
| +1% | +$133K | 0.28% | 73 |
|
|
2024
Q1 | $11.6M | Sell |
12,003
-278
| -2% | -$268K | 0.39% | 51 |
|
|
2023
Q4 | $10.8M | Sell |
12,281
-25
| -0.2% | -$22K | 0.37% | 57 |
|
|
2023
Q3 | $10.1M | Sell |
12,306
-394
| -3% | -$324K | 0.41% | 55 |
|
|
2023
Q2 | $9.13M | Buy |
12,700
+75
| +0.6% | +$53.9K | 0.33% | 67 |
|
|
2023
Q1 | $10.4M | Sell |
12,625
-327
| -3% | -$269K | 0.38% | 65 |
|
|
2022
Q4 | $9.34M | Sell |
12,952
-809
| -6% | -$584K | 0.36% | 69 |
|
|
2022
Q3 | $9.48M | Sell |
13,761
-1
| -0% | -$689 | 0.42% | 59 |
|
|
2022
Q2 | $8.14M | Sell |
13,762
-183
| -1% | -$108K | 0.34% | 72 |
|
|
2022
Q1 | $9.74M | Sell |
13,945
-181
| -1% | -$126K | 0.34% | 69 |
|
|
2021
Q4 | $8.92M | Sell |
14,126
-251
| -2% | -$159K | 0.3% | 77 |
|
|
2021
Q3 | $8.7M | Sell |
14,377
-338
| -2% | -$205K | 0.32% | 78 |
|
|
2021
Q2 | $8.22M | Buy |
+14,715
| New | +$8.22M | 0.36% | 76 |
|
|
2020
Q3 | – | Sell |
-63
| Closed | -$39K | – | 777 |
|
|
2020
Q2 | $39K | Buy |
63
+36
| +133% | +$22.3K | ﹤0.01% | 512 |
|
|
2020
Q1 | $13K | Buy |
27
+10
| +59% | +$4.82K | ﹤0.01% | 694 |
|
|
2019
Q4 | $6K | Buy |
+17
| New | +$6K | ﹤0.01% | 848 |
|
|
2019
Q3 | – | Sell |
-7
| Closed | -$2K | – | 890 |
|
|
2019
Q2 | $2K | Sell |
7
-65
| -90% | -$18.6K | ﹤0.01% | 760 |
|
|
2019
Q1 | $30K | Buy |
+72
| New | +$30K | ﹤0.01% | 404 |
|
|
2016
Q1 | – | Sell |
-2
| Closed | -$3K | – | 763 |
|
|
2015
Q4 | $3K | Buy |
+2
| New | +$3K | ﹤0.01% | 623 |
|